Zhong Xiaoqi,Wang Qinlin,Liang Huiwei,Li Xuan,Yang Chanjuan,Analysis of participants drop-out in antidepressant clinical trials and related influencing factors[J].SICHUAN MENTAL HEALTH,2021,34(5):440-443
Analysis of participants drop-out in antidepressant clinical trials and related influencing factors
DOI:10.11886/scjsws20210225002
English keywords:Antidepressant  Clinical trial  Participant  Drop-out  Influencing factors
Fund projects:广东省自然科学基金项目(项目名称:探索磷脂酰丝氨酸对携带SERINC2突变的双相障碍患者的干预作用,项目编号:2018A030313283)
Author NameAffiliationPostcode
Zhong Xiaoqi The Affiliated Brain Hospital of Guangzhou Medical University Guangzhou 510370 China 510370
Wang Qinlin The Affiliated Brain Hospital of Guangzhou Medical University Guangzhou 510370 China 510370
Liang Huiwei The Affiliated Brain Hospital of Guangzhou Medical University Guangzhou 510370 China 510370
Li Xuan The Affiliated Brain Hospital of Guangzhou Medical University Guangzhou 510370 China 510370
Yang Chanjuan The Affiliated Brain Hospital of Guangzhou Medical University Guangzhou 510370 China 510370
Hits:
Download times:
English abstract:
      Objective To analyze the drop-out rate of participants in antidepressant clinical trials and to explore the related influencing factors.Methods A retrospective analysis was carried out on the participants of 9 antidepressant clinical trials conducted at the Affiliated Brain Hospital of Guangzhou Medical University from 2013 to 2020. A self-compiled questionnaire was used to collect the subjects' demographic data, disease characteristics and the final completion of the trial, thereafter, the participant drop-out rate and related influencing factors were discussed.Results A total of 157 cases were enrolled, including 120 cases completed and 37 cases dropped out the trail. The causes of drop-out were poor efficacy in 13 cases (35.14%), presence of adverse reactions in 12 cases (32.43%), withdrawal of informed consent in 8 cases (21.62%) and loss of follow-up in 4 cases (10.81%). Correlation analysis showed that participant drop-out was positively correlated with the level of anxiety (r=0.224, P<0.01) and presence of adverse events (r=0.158, P<0.05), meantime, negatively correlated with the level of education (r=-0.209, P<0.01) and overall efficacy (r=-0.545, P<0.01). Binary Logistic regression analysis showed that education level (β=-0.611, OR=0.543, P<0.05), number of visits (β=-1.831, OR=0.160, P<0.01) and overall efficacy (β=-2.286, OR=0.102, P<0.01) were the influencing factors of participant drop-out.Conclusion Low education level, first visit, poor outcome, high level of anxiety, and adverse events are the factors affecting participant drop-out in antidepressant clinical trials.
View Full Text   View/Add Comment  Download reader
Close